Related Experiment Video
Updated: Jun 13, 2026

Clinical Efficacy of an Innovative Multidimensional Traction Therapy in Moderate Adolescent Idiopathic Scoliosis
Published on: February 10, 2026
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of
Ami Baba1, Maureen Smith2, Beth K Potter3
1Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
Insights
New CONSORT-Children and Adolescents (CONSORT-C) 2026 guidelines improve reporting for paediatric randomized controlled trials (RCTs). This ensures better use of research findings for children and adolescents, reducing waste.
Area of Science:
- * Clinical Trials Methodology
- * Pediatric Research
- * Health Research Reporting Standards
Background:
- * High-quality randomized controlled trials (RCTs) in children and adolescents are crucial for informing healthcare decisions.
- * Current reporting practices often lack completeness and transparency, hindering critical evaluation of pediatric RCTs.
- * Standardized, evidence-based reporting guidelines are needed to reduce research waste in pediatric RCTs.
Purpose of the Study:
- * To introduce the CONSORT-Children and Adolescents (CONSORT-C) 2026 reporting guideline.
- * To enhance the quality and completeness of reporting for pediatric RCTs involving participants aged 0-19 years.
- * To provide a minimum set of reporting items reflecting the priorities of all stakeholders.
Main Methods:
- * Development informed by the EQUATOR Network framework.
- * Literature review to identify candidate reporting items.
- * Input from a Youth Advisory Group and a Family Caregiver Advisory Group.
- * International Delphi study, consensus meeting, and pilot testing.
Main Results:
- * CONSORT-C 2026 includes a checklist with 13 new reporting items.
- * One item is youth-generated, and six are youth-endorsed.
- * An accompanying explanation and elaboration paper provides detailed guidance and examples.
Conclusions:
- * CONSORT-C 2026 offers a minimum standard for reporting pediatric RCTs.
- * Implementation aims to optimize the usability and reproducibility of trial results.
- * Adoption of CONSORT-C 2026 is expected to reduce research waste and improve evidence-based practice for young people.
Abstract:
Appropriately designed, conducted, and reported randomised controlled trials (RCTs) in children and adolescents inform treatment and health-care decisions made by young people, families, researchers, clinicians, regulators, funders, policy makers, and other interest holders. To critically evaluate, interpret, and apply trial results, readers require access to a complete and transparent report of what was planned, done, and found, taking unique considerations specific to children and adolescents into account. Harmonised guidance based on evidence and consensus is needed to optimise standardised reporting and reduce research waste in paediatric RCTs. As an extension to the Consolidated Standards of Reporting Trials (CONSORT) 2025 statement, the CONSORT-Children and Adolescents (CONSORT-C) 2026 reporting guideline aims to improve the quality and completeness of reporting of paediatric RCTs that involve participants aged 0-19 years. The Enhancing the Quality of Transparency of Health Research (EQUATOR) Network's published framework primarily informed the development of CONSORT-C 2026. A literature review was conducted to generate a list of candidate reporting items. To obtain direct input from young people and family caregivers throughout the project, a Youth Advisory Group and a Family Caregiver Advisory Group were formed. An international Delphi study with a priori consensus thresholds, consensus meeting, group writing of the explanation and elaboration paper, and pilot testing were conducted. CONSORT-C 2026 consists of a checklist with 13 new reporting items, including one youth-generated and six youth-endorsed items; the accompanying explanation and elaboration paper explains all items and offers examples of good reporting. CONSORT-C 2026 can be considered a minimum set of reporting items applicable to paediatric RCT reports reflecting the priorities of clinicians, researchers, young people, family caregivers, and other interest holders. Widespread implementation and uptake of CONSORT-C 2026 should optimise the usability of trial results for these populations, improve the reproducibility of trial results, and reduce research waste.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Sex Linked Disorders
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Sex-linked Disorders
